Interstitial Lung Disease Trial, Recruiting (NCT00001456)

Interstitial Lung Disease Trial, Recruiting NCT00001456 Sponsor: National Human Genome Research Institute (NHGRI) Condition: Interstitial Lung Disease

Printed from Voxsanity (voxsanity.com.au) — NCT00001456 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Interstitial Lung Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

"Who might be able to join this trial:

People diagnosed with Hermansky-Pudlak Syndrome (HPS) between the ages of 1 and 80 years old may be eligible.
Family members who are caregivers for someone with HPS, between the ages of 1 and 80, may also be eligible.
A diagnosis of HPS can be confirmed either through a special microscope test that looks at blood platelets, or through genetic testing that identifies changes in HPS-related genes.
People who have not been formally diagnosed with HPS may still be considered if they have albinism (reduced pigmentation in skin, hair, and eyes) and a problem with how their blood platelets store certain substances (confirm with trial site).
People taking part only in a symptom questionnaire portion of the study must be at least 18 years old.

Who may not be able to join:

Women who are currently pregnant are not eligible.
Adults who are unable to give their own consent to participate are not eligible.

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Wendy J Introne, M.D., National Human Genome Research Institute (NHGRI)

Phone: (301) 451-8879

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT00001456

Sponsor: National Human Genome Research Institute (NHGRI)

Phase: Not Applicable

Status: Recruiting

Condition: Interstitial Lung Disease

Trial contact: (301) 451-8879

More information: https://clinicaltrials.gov/study/NCT00001456

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

"Who might be able to join this trial:

People diagnosed with Hermansky-Pudlak Syndrome (HPS) between the ages of 1 and 80 years old may be eligible.
Family members who are caregivers for someone with HPS, between the ages of 1 and 80, may also be eligible.
A diagnosis of HPS can be confirmed either through a special microscope test that looks at blood platelets, or through genetic testing that identifies changes in HPS-related genes.
People who have not been formally diagnosed with HPS may still be considered if they have albinism (reduced pigmentation in skin, hair, and eyes) and a problem with how their blood platelets store certain substances (confirm with trial site).
People taking part only in a symptom questionnaire portion of the study must be at least 18 years old.

Who may not be able to join:

Women who are currently pregnant are not eligible.
Adults who are unable to give their own consent to participate are not eligible.

Important: Always verify eligibility with the trial site directly before applying."

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

National Human Genome Research Institute (NHGRI)

Registry

ClinicalTrials.gov

Start date

6 November 1995

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Natural History

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov